Monte Rosa Therapeutics

Monte Rosa Therapeutics: Next-generation molecular glue-based targeted protein degradation platform developing small molecule therapeutics that selectively degrade disease-causing proteins. Targeting the undruggable proteome in oncology and non-oncology indications via AI based degron prediction. Extensive in vivo data to date has demonstrated potent anti-tumor activity. Lead program focused on GSPT1, a key regulator and vulnerability of Myc-induced translational addiction. DC selection for lead program expected in 2021.
Based in...
Public, USA
Market Cap
1B +
Basel, Basel-Stadt

Company Participants at Solebury Trout Hamptons CEO Roundtable 2021

  • Ajim Tamboli, CFO

Top 10 Holders of Monte Rosa Therapeutics, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
NEA Management Co. 17.31 7,703,205 268.92 13F 6/30/21
Fidelity Management & Research Co. LLC 9.64 4,289,159 149.73 13F 6/30/21
Avoro Capital Advisor LLC 7.44 3,311,434 115.60 13F 6/30/21
Cormorant Asset Management LP 7.18 3,193,973 111.50 13F 6/30/21
T. Rowe Price Associates, Inc. (Investment Management) 6.15 2,737,654 95.57 13F 6/30/21
HBM Partners AG (Investment Management) 4.82 2,143,216 74.82 Funds 6/30/21
Aisling Capital Management LP 3.31 1,472,331 51.40 13F 6/30/21
BlackRock Advisors LLC 2.98 1,326,751 46.32 13F 6/30/21
RTW Investments LP 2.73 1,214,572 42.40 13F 6/30/21
Casdin Capital LLC 2.16 960,883 33.54 13F 6/30/21
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.